Andrea Ogle
15 Papers
2 Citations
Andrea Ogle is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 15 publications.
Chat about Author
Papers
LINC-08. Neuro-Oncology tumor board – one-year experience of international collaboration
Margaret Shatara,Evan Cantor,Ashley Meyer,Andrea Ogle,Kimberly Hofmann,T. Green,Mary Beck,Michele McHugh,Nicole M. Brossier,Andrew Cluster,Ali Mian,Sonika Dahiya,Zeyad Abdelaziz,Shady Fadel,Nahla Ali Mobark,Musa Alharbi,Soad K Aljaouni,Abrar Aljunaid,Waleed Said,Moatasem El-Ayadi,Madeha Mahmoud,Abeer Al-Battashi,Imen Chabchoub,Nisreen Khalifa,Nora F. Dengler,Pablo Hernáiz Driever,Nicolás Rojas del Río,Bożenna Dembowska-Bagińska,Marta Perek-Polnik,Szymon Skoczeń,Hetal Dholaria,Sumanth Nagabushan,M. Oliveira,Angela C. Hirbe,Amy E. Armstrong,David D. Limbrick,David H. Gutmann,Mohamed S. AbdelBaki +37 more
TL;DR: This initiative is expected to provide a platform for future international research collaborations and deliver the optimal medical care for neuro-oncology patients globally and promote a multi-disciplinary approach for the management of pediatric CNS tumors.
2
EPCT-07. Updated report on the pilot study of using MRI-guided laser heat ablation to induce disruption of the peritumoral blood brain barrier to enhance deliver and efficacy of treatment of pediatric brain tumors
Margaret Shatara,Karen Gauvain,Evan Cantor,Ashley Meyer,Andrea Ogle,Michele McHugh,Mary Beck,T. Green,Allison A. King,Andrew Cluster,Nicole M. Brossier,Joshua S. Shimony,Mohamed S. AbdelBaki,David Tran,Jian Campian,Eric C. Leuthardt,Joshua B. Rubin,David D. Limbrick +17 more
TL;DR: LITT is safe in children with brain tumors and can be combined with chemotherapy, and peritumoral BBB disruption was evident up to 4 months post-procedure.
2
LGG-38. Dose-dependent seizure control for an NF1 patient treated via MEK-inhibition for optic pathway glioma
Evan Cantor,Ashley Meyer,Andrea Ogle,Margaret Shatara,Andrew Cluster,Mohamed S. AbdelBaki,Stephanie M. Morris,Judith L.Z. Weisenberg,Nicole M. Brossier +8 more
TL;DR: MEK inhibition may have a clinically relevant anti-seizure effect for patients with pediatric LGG or NF1, and improvements in weakness and academic performance may have been due to improved seizure control or a direct effect of MEK inhibition on NF1-heterozygous neurons.
1
GCT-06. Management of a congenital intracranial teratoma: a case report and review of literature
Margaret Shatara,Evan Cantor,Kristie N. Ramos,Jonathan Yu,Ahmad Hassan,Joshua S. Shimony,Peng Han,Ashley Meyer,Andrea Ogle,Michele McHugh,T. Green,M Beck,Andrew Cluster,Nicole M. Brossier,Joshua B. Rubin,Sonika Dahiya,Mohamed S. AbdelBaki,Jennifer Strahle +17 more
TL;DR: A patient with a congenital mature teratoma diagnosed prenatally, who underwent successful surgical resection following neoadjuvant chemotherapy is reported, with no evidence of immature components on final pathology.
1
MEDB-54. Standard Risk Medulloblastoma treated solely with surgery and chemo-radiation
Evan Cantor,Ashley Meyer,Andrea Ogle,Michele McHugh,Mary Beck,T. Green,Lakshmi Ramachandran,Sonika Dahiya,Andrew Cluster,Nicole M. Brossier,Mohamed S. AbdelBaki,David D. Limbrick,Stephanie M. Perkins,Margaret Shatara +13 more
TL;DR: A unique case of an adolescent male with an standard-risk medulloblastoma, who achieved remission with only radiotherapy is reported, to minimize long-term adverse events associated with current therapies.